Dr. Reddy’s launches Levocetirizine Dihydrochloride allergy tablets in US market


Dr. Reddy’s Laboratories Ltd has launched Levocetirizine Dihydrochloride tablets, an over-the-counter therapeutic equal generic model of Xyzal Allergy 24HR tablets, within the US market. Xyzal is a registered trademark of the UCB group of firms.

Levocetirizine Dihydrochloride tablets are an over-the-counter antihistamine used for 24-hour aid from allergy signs reminiscent of watery eyes, runny nostril, itching eyes/nostril, and sneezing. “This primary-to-market launch for the shop model is the testomony to the deep capabilities of our retailer model OTC enterprise,” Milan Kalawadia, Vice-President and Head, US Over-the-Counter and Speciality Rx companies, Dr. Reddy’s Laboratories, mentioned in a launch issued right here on Friday.

“We stay up for collaborating with our prospects to carry high-quality, reasonably priced retailer model options to the market.” The Xyzal Allergy 24HR tablets model had US gross sales of roughly $71 million for the newest 12 months ending in January 2018, in line with IRI. Dr. Reddy’s Levocetirizine Dihydrochloride Tablets USP is obtainable in 5 mg energy and in varied consumer-oriented package deal sizes.


Supply hyperlink